Articles tagged with Type 2 Diabetes
Researchers at Sahlgrenska Academy discovered that gut microbiota in people with type 2 diabetes produces a substance impairing insulin response. This finding highlights the importance of diet and gut microbiota interaction in understanding metabolism in health and disease.
A study of over 10,000 participants with type 2 diabetes found that intensive blood sugar control and targeting low blood pressure reduced the risk of macroalbuminuria, but had no impact on more significant kidney outcomes. The use of fenofibrate to lower cholesterol increased the risk for doubling of serum creatinine.
A recent study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that midlife women transitioning to menopause have a higher risk of developing metabolic syndrome. The study identified central obesity as the most common factor, but also showed that physically active women were less likely to deve...
A new study found that fasting hyperglucagonemia in type 2 diabetes is associated with higher waist-to-hip ratio, poor glycemic control, and increased insulin concentrations. Visceral fat deposition may play a role in the development of this condition.
Among pediatric patients aged 20 or younger, there was a notable increase in vertical sleeve gastrectomy and a decrease in laparoscopic Roux-en-Y gastric bypass procedures between 2005-2014. The use of adjustable gastric bands also decreased during this time period, reflecting trends seen in adult metabolic bariatric surgery procedures.
A recent GWAS analysis of latent autoimmune diabetes in adults (LADA) has uncovered new connections to type 1 and type 2 diabetes, suggesting a hybrid nature of the disorder. The study found that genetic signals linked to LADA were mainly shared with established variants known to be linked to T1D.
Bariatric surgery was associated with a lower risk of macrovascular disease events at five years of follow-up compared to usual medical care. The findings suggest that bariatric surgery may help reduce patient risk, but more confirmation is needed in randomized clinical trials.
A large prospective cohort study found that higher levels of prolactin in women are associated with a lower risk of developing type 2 diabetes. Women with the highest 25% of prolactin levels were 27% less likely to develop T2D than those in the lowest 25%. The association was similar regardless of menopausal status and other risk factors.
A study of over 60,000 adults found that higher biomarker levels for dairy fat consumption are associated with a lower risk of developing type 2 diabetes. The researchers suggest re-examining the metabolic benefits of dairy fat, but note limitations and potential biases in their findings.
A new study suggests that planned intermittent fasting can help reverse type 2 diabetes by cutting out the need for insulin treatment and controlling blood glucose levels. Three men with type 2 diabetes were able to stop taking insulin after following a fasting regimen for around 10 months.
Scientists have discovered a way to restore normal insulin cell function in type 2 diabetes by blocking a protein called VDAC1. The study showed that the substance can prevent the development of the disease and improve glucose control. Further studies are needed, but the findings offer new hope for treatment options.
The new guidelines update previous recommendations, prioritizing patient-centric care, medication adherence, and lifestyle management. They also highlight the importance of metabolic surgery, metformin as first-line therapy, and personalized medication selection based on patient preferences and comorbidities.
A new study found that 21% of individuals with insulin-treated diabetes diagnosed after age 30 have severe insulin deficiency, characteristic of late-onset type 1 diabetes. These patients often experience delays in diagnosis and treatment due to misdiagnosis as type 2 diabetes.
A study funded by NIH found that gastric banding is as effective as metformin in stabilizing disease for people with prediabetes or new-onset type 2 diabetes. Participants who underwent gastric banding surgery lost significantly more weight and showed similar improvements in insulin sensitivity compared to those taking metformin.
A Japanese study found that increased fasting glucose, higher BMI, and impaired insulin sensitivity were detectable up to 10 years before the diagnosis of diabetes as well as prediabetes. The study suggests that elevated metabolic markers for diabetes may be detectable more than 20 years before its diagnosis.
The study found large regional variations in diabetes prevalence, with North America and the Caribbean having high current rates, while Africa has low rates despite moderate obesity. If obesity rates are reduced by 25%, millions of cases of diabetes can be prevented, especially in Africa.
Researchers found that lixisenatide slowed the progression of kidney damage in patients with macro-albuminuria and type 2 diabetes. The study showed a statistically significant reduction in urinary albumin-to-creatinine ratio and a borderline significant reduction in risk of incidence of macroalbuminuria.
A large observational study found that individuals with diabetes are at a higher risk of developing certain cancers, including colorectal and breast cancer. The study also showed that people with diabetes who are diagnosed with cancer have poorer survival rates compared to those without diabetes.
A new study has found a strong association between diabetes and an increased risk of developing osteoarthritis, rheumatoid arthritis, and osteoporosis. People with diabetes were 33% more likely to suffer from osteoarthritis than their counterparts without diabetes.
A large observational study found that adults with type 2 diabetes are at greater risk of dying from cancer, particularly obesity-related cancers. Non-obesity related cancers also pose a significant threat to individuals with type 2 diabetes.
A new study found that younger age at diagnosis, higher body mass index, and a maternal family history of diabetes are associated with faster disease progression in type 2 diabetes. The research used data from the UK BioBank to identify these factors and their impact on disease progression.
Research reveals that women with versus without prediabetes experience significantly larger adverse differences in cardiometabolic health compared to men. Women with prediabetes had higher blood pressure, worse cholesterol profiles, and increased inflammation before the onset of type 2 diabetes.
A new study published in The Lancet found that albiglutide, a GLP-1 receptor agonist, reduces the risk of major adverse cardiovascular events by 22% in patients with type 2 diabetes and established cardiovascular disease. This result is comparable to traditional cardiovascular drugs.
A study found that a gene variant commonly associated with Type 2 diabetes may also increase the risk of being lean, contradicting common assumptions about obesity and diabetes. Researchers analyzed data from over 9,000 Hispanic Latinos and used complex modeling to estimate the odds of developing Type 2 diabetes across time.
Researchers found that SHBG levels at baseline can predict insulin resistance years later in both men and women. Lower SHBG levels are associated with higher insulin resistance, a precursor to type 2 diabetes.
A new study suggests that weight loss can put type 2 diabetes into remission by improving pancreatic beta cell function. Nearly half of participants who lost fat from around the liver and pancreas achieved diabetes remission, compared to six in the control group.
A large meta-analysis of over 191,000 postmenopausal women found that early menopause and premature ovarian failure are associated with a higher risk of developing type 2 diabetes. Women who begin menopause before age 40 are 50% more likely to develop the disease than those with normal menopause between ages 45-55.
A new study reveals that gastric bypass surgery reduces all-cause mortality risk by 49% and cardiovascular disease risk by 34% in obese patients with type 2 diabetes. However, it also increases the risk of anaemia, malnutrition, and psychiatric diagnoses.
Research shows that weight gain between childhood and adulthood increases type 2 diabetes risk more than a stable high body mass index. Children who were overweight at age 10 and remained so have lower T2D risk compared to those who were normal weight but became overweight later in life.
Researchers found significant reductions in mean glucose and other glycemic factors when adding dapagliflozin to metformin or insulin in patients with type 2 diabetes. Greater improvements were seen in patients taking metformin compared to insulin.
A new study reveals that diuretic drug use in individuals with type 2 diabetes is associated with a significantly increased risk of serious problems in their lower limbs, leading to amputation. The research found that diuretics should be used cautiously in patients at risk of amputations.
A recent study has shown that adding genetic factors to existing risk assessments can help predict future major coronary events in people with type 2 diabetes. The genetic score provides a significant improvement in correctly predicting cardiovascular risk, particularly when used early in life.
Researchers found that online participants lost an average of 10.3 pounds at 6 months and 8.8 pounds at 12 months, comparable to in-person program results. The online program also showed better participation rates than the in-person program.
A new genomic study reveals five distinct groups of DNA sites driving unique forms of type 2 diabetes, with potential implications for personalized treatment approaches. The research identifies subtypes based on genetics and physiology, which could help physicians tailor interventions to individual patients.
A new study reveals that changes in white matter regions of the brain associated with small vessel disease are linked to decreased processing speed in people with Type 2 diabetes. Higher blood pressure and worse kidney function also contribute to poorer cognition.
A new study from the University of Iowa found that 8.5% of American adults have been diagnosed with type 2 diabetes, while 0.5% have type 1 diabetes. Type 2 diabetes is overwhelmingly more common, accounting for 91.2% of all diagnosed cases.
Researchers developed a novel HTS assay and miniaturized it to identify small molecule modulators of GPR119, a promising target for treating type 2 diabetes. The study screened over 500,000 compounds and identified 200 modulators, paving the way for new treatments.
Research finds cardiorespiratory fitness, high-intensity physical activity and low sedentary time all lower type 2 diabetes risk. The study, published in Diabetologia, suggests that a combination of these traits may be more beneficial than individual components.
University of Tokyo researchers have developed a trans-omics approach that maps the interactions between molecules inside cells in response to insulin. This comprehensive understanding may lead to better therapies for type 2 diabetes by identifying potential drug targets and optimizing insulin regimens.
The NIH grant will aid research in understanding how to prevent kidney damage and failure caused by type 2 diabetes. Tubular epithelial cells play a crucial role in kidney function and require high amounts of lipids and fatty acids to work correctly, but people with type 2 diabetes have lipid metabolism derailments.
A recent study found that statins do not reduce cardiovascular disease or death in healthy individuals aged 75 and older. However, in people with type 2 diabetes aged 75-84 years, statins were associated with a significant reduction in cardiovascular disease and death. The protective effect declined after age 85.
A comprehensive study from Chalmers University of Technology confirms whole grains as a crucial food group for preventing type 2 diabetes. The study found that consuming more than 50g of whole grain per day can reduce the risk of developing the disease by up to 34%.
Researchers found that nalbuphine effectively treated opioid-induced urine retention in a patient, suggesting it as a potential solution for those unable to use catheters. WHO guidelines also recently made recommendations on treatment intensification for type 2 diabetes and insulin use for type 1 and type 2 diabetes.
Researchers discovered a protein called HIF helps heart cells survive after a heart attack, but its effect is blocked by fats accumulating within the heart muscle in people with diabetes. Repurposed drugs that activate HIF may help prevent lasting heart muscle damage and improve recovery in Type 2 diabetics.
Research analyzed data from over 25,000 individuals in China to determine early life nutrition's role in metabolic disorders. The study found significant associations between low birth weight and increased risk of obesity, diabetes, and hypertension.
A new study found that overweight mice with Type 2 diabetes who don't sleep well need more time to heal their wounds compared to healthy mice. The research suggests that sleep plays a crucial role in wound healing among obese mice with Type 2 diabetes.
A new expert review outlines the clinical characteristics of bone fragility in adults with diabetes and provides valuable insights for diagnosis and treatment. The review highlights recent studies on bone mineral density, biochemical markers, and fracture prediction to inform clinicians about the optimal approach to managing bone healt...
Researchers found that a blood test conducted as early as the 10th week of pregnancy may help identify women at risk for gestational diabetes. The study suggests that measuring HbA1c levels in early pregnancy could determine a woman's later risk for the condition, allowing for lifestyle changes to reduce the risk.
A study of 300,000 type 2 diabetes patients found that those with controlled risk factors had a significantly low risk of premature death, heart attack, and stroke. Optimizing medication, not smoking, and managing other risk factors can greatly reduce the risk.
A new study from Harvard T.H. Chan School of Public Health found that people who gain weight after quitting smoking may face a temporary increase in type 2 diabetes risk, directly proportional to the weight gain. However, quitters can still reap significant health benefits, including lower cardiovascular disease and cancer risks.
A study in Guatemala finds type 2 diabetes and pre-diabetes affect 25% of the indigenous population, with age being a significant risk factor rather than obesity. The prevalence has more than doubled since 2003, and researchers attribute this to aging, increased physical inactivity, and insulin resistance.
Researchers found that fat fibrosis in subcutaneous fat is predictive of unhealthy belly fat and insulin resistance in Asian participants. This difference could help explain why Asians develop type 2 diabetes at a lower body weight than Caucasians.
A recent study found that nearly half of individuals with type 2 diabetes achieved remission after a weight-loss intervention. The research suggests that substantial weight loss at diagnosis can rescue beta cells and reverse the condition. However, only those who experienced early and sustained improvement in beta-cell function were ab...
A new study by the University of Exeter found that considering patient characteristics such as sex and BMI can significantly improve treatment outcomes in type 2 diabetes. The research suggests that obese females are more likely to have good blood glucose control on thiazolidinediones, while non-obese males benefit from sulfonylureas.
A recent study found that just two weeks of inactivity can hasten the onset of Type 2 diabetes and elevate blood sugar levels among pre-diabetic patients. The study's findings suggest that seniors who experience periods of physical inactivity are more likely to suffer harmful consequences to their overall health.
Experts from the University of Stirling have made a breakthrough in understanding how people respond to lifestyle treatment for preventing Type 2 diabetes. A new genomic signature has been discovered that indicates improved insulin sensitivity in individuals whose Type 2 diabetes status improves following a treatment intervention.
A two-day intermittent calorie restriction diet was found to be effective for glycemic control in patients with type 2 diabetes, comparable to a daily calorie restriction diet. The study suggests that this approach may be more sustainable than traditional daily calorie restriction diets.
A recent study published in Respiration has found that people with type 2 diabetes are significantly more likely to suffer from breathlessness and restrictive lung disease. The research team also discovered an association between albuminuria and RLD, suggesting a possible link between lung and kidney diseases.
Despite lack of evidence, physicians recommend self-monitoring due to its potential for lifestyle change and patient activation. However, opponents cite concerns over efficacy and office-based education's negative impact on patients.
Researchers at Wake Forest Baptist will investigate lifestyle interventions on cognitive resilience in older adults with type 2 diabetes and obesity. The four-year study aims to confirm earlier findings that intensive lifestyle intervention may decrease cognitive impairment, but paradoxically increase it in those with severe obesity.